Related Experiment Videos

N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration

H P Hammes1, H Hoerauf, A Alt

  • 1Third Medical Department of Internal Medicine, Justus-Liebig-University, Giessen, Germany.

Abstract

Insights

Glycoxidation products and the receptor for advanced glycation end products (RAGE) are present in age-related macular degeneration (ARMD) membranes. Their colocalization with activated NFkB suggests a role in ARMD pathogenesis.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Age-related macular degeneration (ARMD) is a leading cause of vision loss.
  • The role of advanced glycation end products (AGEs) and their receptor (RAGE) in ARMD pathogenesis is under investigation.
  • Glycoxidation products are a type of AGE.

Purpose of the Study:

  • To determine if glycoxidation products and RAGE are present in subfoveal membranes from ARMD patients.
  • To investigate the colocalization of these molecules within the membranes.
  • To explore the potential involvement of NFkB signaling.

Main Methods:

  • Immunohistochemistry was used to analyze surgically removed subfoveal fibrovascular membranes.
  • The study examined 11 membranes from ARMD patients and 1 idiopathic membrane.
  • Specific markers analyzed included N(epsilon)-(carboxymethyl)lysin (CML), RAGE, and activated NFkB (p50).

Main Results:

  • CML-like immunoreactivity and RAGE were found in all ARMD membranes, often colocalized.
  • RAGE was detected in CD68-positive cells and the fibrous matrix.
  • Activated NFkB (p50) was present in CD68-positive cells and surrounding areas.

Conclusions:

  • Glycoxidation products are present in subretinal membranes associated with ARMD.
  • The co-expression of RAGE and activated NFkB suggests their involvement in ARMD pathogenesis.
  • These findings highlight a potential therapeutic target related to AGEs and RAGE signaling in ARMD.

Related Concept Videos